Umizortamig

Approval Year

Name

Type

Language

Umizortamig

Official Name

English

scFv-G1-scFv-scFv fused heavy chain humanized and chimeric (1-1231)[scFv kappa-heavy anti-CD3E and CD3G humanized (1-252) [V-KAPPA (Homo sapiens IGKV1-5*01 (90.1%) -IGKJ4*01 (90.9%), CDR-IMGT[6.3.14] (27-32.50-52.89-102)) (1-112) -20-mer tetrakis(tetragl

Common Name

English

umizortamig [INN]

Common Name

English

Immunoglobulin, tetraspecific, anti-(human CD3 antigen ε-chain and γ-chain) (human-Oryctolagus cuniculus clone 284A10 single-chain variable fragment VL-(GGGGS)4-VH) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin G1 anti-

Common Name

English

immunoglobulin scFv-G1-scFv-scFv_L-kappa, anti-[Homo sapiens EGFRvIII (epidermal growth factor receptor (receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB) variant III)], anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4) and CD3G], anti-[Homo

Common Name

English

Code System Code Type Description

CAS

2599198-83-9

Created by admin on Sat Dec 16 19:29:11 GMT 2023 , Edited by admin on Sat Dec 16 19:29:11 GMT 2023

PRIMARY

INN

12292

Created by admin on Sat Dec 16 19:29:11 GMT 2023 , Edited by admin on Sat Dec 16 19:29:11 GMT 2023

PRIMARY

FDA UNII

KX8KZX98PB

Created by admin on Sat Dec 16 19:29:11 GMT 2023 , Edited by admin on Sat Dec 16 19:29:11 GMT 2023

PRIMARY

ACTIVE MOIETY


					KX8KZX98PB

Umizortamig